A human clinical trial examining the safety and efficacy of a "functional cure" for type 1 diabetes is currently underway. Trials of the novel islet cell replacement therapy developed by ViaCyte involve a device containing stem cells being implanted into a patient with type 1 diabetes. It's hoped these cells will then mature into human islet tissue with insulin-producing beta cells that produce insulin on demand.
.. Continue Reading Clinical trials of stem cell-based "functional cure" for type 1 diabetes underwayCategory: Medical
Tags: Related Articles:
- Capsules made from seaweed could replace insulin injections
- Protective packaging could hold the key to an effective insulin pill
- Injectable polymer could cut insulin injections to one per month
- FDA clears first-ever artificial pancreas for automated insulin delivery
- New diabetes treatment would turn liver cells into insulin-producers
- Encapsulated cells could free diabetics from insulin injections
from New Atlas http://ift.tt/2vkJdNu
No comments:
Post a Comment